156 related articles for article (PubMed ID: 26391107)
1. Attitudes of Australian dermatologists to the use and safety of topical corticosteroids in paediatric atopic dermatitis.
Smith SD; Lee A; Blaszczynski A; Fischer G
Australas J Dermatol; 2016 Nov; 57(4):278-283. PubMed ID: 26391107
[TBL] [Abstract][Full Text] [Related]
2. Pharmacists' knowledge about use of topical corticosteroids in atopic dermatitis: Pre and post continuing professional development education.
Smith SD; Lee A; Blaszczynski A; Fischer G
Australas J Dermatol; 2016 Aug; 57(3):199-204. PubMed ID: 25846602
[TBL] [Abstract][Full Text] [Related]
3. Topical Corticosteroid Phobia among Parents of Children with Atopic Eczema in Korea.
Lee JY; Her Y; Kim CW; Kim SS
Ann Dermatol; 2015 Oct; 27(5):499-506. PubMed ID: 26512163
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the influence of family and friends, and the Internet on patient perceptions of long-term topical corticosteroid use.
Smith SD; Farrugia LL; Harris V; Lee A; Carter SR; Blaszczynski A; Fischer G
J Dermatolog Treat; 2017 Nov; 28(7):642-646. PubMed ID: 28349719
[TBL] [Abstract][Full Text] [Related]
5. The knowledge of issues associated with topical corticosteroids using in patients with atopic dermatitis.
Jaworek A; Szafraniec K; Pastuszczak M; Zalewski A; Wojas-Pelc A
Pol Merkur Lekarski; 2019 Jun; 46(276):243-247. PubMed ID: 31260432
[TBL] [Abstract][Full Text] [Related]
6. Parental knowledge of topical therapies in the treatment of childhood atopic dermatitis.
Beattie PE; Lewis-Jones MS
Clin Exp Dermatol; 2003 Sep; 28(5):549-53. PubMed ID: 12950351
[TBL] [Abstract][Full Text] [Related]
7. General practitioners knowledge about use of topical corticosteroids in paediatric atopic dermatitis in Australia.
Smith SD; Harris V; Lee A; Blaszczynski A; Fischer G
Aust Fam Physician; 2017; 46(5):335-340. PubMed ID: 28472581
[TBL] [Abstract][Full Text] [Related]
8. Adverse effects of topical corticosteroids in paediatric eczema: Australasian consensus statement.
Mooney E; Rademaker M; Dailey R; Daniel BS; Drummond C; Fischer G; Foster R; Grills C; Halbert A; Hill S; King E; Leins E; Morgan V; Phillips RJ; Relic J; Rodrigues M; Scardamaglia L; Smith S; Su J; Wargon O; Orchard D
Australas J Dermatol; 2015 Nov; 56(4):241-51. PubMed ID: 25752907
[TBL] [Abstract][Full Text] [Related]
9. The caseload, assessment and treatment of atopic dermatitis: a survey of Australian dermatologists.
Stephens RB; Cooper A
Australas J Dermatol; 1999 Nov; 40(4):187-9. PubMed ID: 10570552
[TBL] [Abstract][Full Text] [Related]
10. Topical corticosteroid phobia in atopic dermatitis: a study of its nature, origins and frequency.
Aubert-Wastiaux H; Moret L; Le Rhun A; Fontenoy AM; Nguyen JM; Leux C; Misery L; Young P; Chastaing M; Danou N; Lombrail P; Boralevi F; Lacour JP; Mazereeuw-Hautier J; Stalder JF; Barbarot S
Br J Dermatol; 2011 Oct; 165(4):808-14. PubMed ID: 21671892
[TBL] [Abstract][Full Text] [Related]
11. Topical corticosteroid phobia in parents of pediatric patients with atopic dermatitis: a multicentre survey.
El Hachem M; Gesualdo F; Ricci G; Diociaiuti A; Giraldi L; Ametrano O; Occella C; Fortina AB; Milioto M; Arcangeli F; Simonetti O; Giancristoforo S; Calamelli E; Mazzatenta C; Neri I
Ital J Pediatr; 2017 Feb; 43(1):22. PubMed ID: 28245844
[TBL] [Abstract][Full Text] [Related]
12. Topical Corticosteroid Phobia in Atopic Dermatitis: A Systematic Review.
Li AW; Yin ES; Antaya RJ
JAMA Dermatol; 2017 Oct; 153(10):1036-1042. PubMed ID: 28724128
[TBL] [Abstract][Full Text] [Related]
13. A labelling system improves parental comfort and willingness to use topical corticosteroids for paediatric atopic dermatitis.
Wilson F; Harnik E; Gore C
Skin Health Dis; 2021 Mar; 1(1):e11. PubMed ID: 35664821
[TBL] [Abstract][Full Text] [Related]
14. Assessment of Topical Corticosteroid Prescribing, Counseling, and Communication Among Dermatologists and Pharmacists.
Millard AN; Stratman EJ
JAMA Dermatol; 2019 Jul; 155(7):838-843. PubMed ID: 30916731
[TBL] [Abstract][Full Text] [Related]
15. Topical Corticosteroid Phobia Among Parents of Children with Atopic Dermatitis (Eczema)- A Cross-Sectional Study.
Albogami MF; AlJomaie MS; Almarri SS; Al-Malki S; Tamur S; Aljaid M; Khayat A; Alzahrani A
Patient Prefer Adherence; 2023; 17():2761-2772. PubMed ID: 37936715
[TBL] [Abstract][Full Text] [Related]
16. Dermatologists' knowledge of and preferences regarding topical steroids.
Sandoval LF; Davis SA; Feldman SR
J Drugs Dermatol; 2013 Jul; 12(7):786-9. PubMed ID: 23884491
[TBL] [Abstract][Full Text] [Related]
17. Topical corticosteroid phobia among caretakers of children with atopic dermatitis: A cross-sectional study using TOPICOP in Japan.
Saito-Abe M; Futamura M; Yamamoto-Hanada K; Yang L; Suzuki K; Ohya Y
Pediatr Dermatol; 2019 May; 36(3):311-316. PubMed ID: 30882946
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the influence of pharmacists and GPs on patient perceptions of long-term topical corticosteroid use.
Farrugia LL; Lee A; Fischer G; Blaszczynski A; Carter SR; Smith SD
J Dermatolog Treat; 2017 Mar; 28(2):112-118. PubMed ID: 27424888
[TBL] [Abstract][Full Text] [Related]
19. A comparison of family physician and dermatologist topical corticosteroid prescriptions: A population-based cross-sectional study.
Bowie AC; Tadrous M; Thiruchelvam D; Ivers NM; Mohan T; Tu K; Jaakkimainen L; Drucker AM
J Am Acad Dermatol; 2023 Jun; 88(6):1291-1299. PubMed ID: 36914480
[TBL] [Abstract][Full Text] [Related]
20. Topical corticosteroid counselling among Malaysian community pharmacists: a qualitative interview study.
Nathan AD; Shankar PR; Sreeramareddy CT
BMC Prim Care; 2023 May; 24(1):119. PubMed ID: 37231354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]